Oscar Health, Inc.
New York Stock ExchangeTotal Valuation
Oscar Health, Inc. carries a market capitalization of 8.10B, placing it among publicly traded companies globally. Its enterprise value stands at 681.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.10B |
| Enterprise Value | 681.49M |
Share Statistics
Oscar Health, Inc. currently has 308.63M shares outstanding.
| Shares Outstanding | 308.63M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Oscar Health, Inc. trades at a trailing price-to-earnings ratio of 14.80. The price-to-sales ratio is 0.53, and the price-to-book ratio stands at 4.29.
| PE Ratio | 14.80 |
| PS Ratio | 0.53 |
| PB Ratio | 4.29 |
| P/TBV Ratio | 4.29 |
| P/FCF Ratio | 1.93 |
| P/OCF Ratio | 1.84 |
Enterprise Valuation
| EV / Sales | 0.04 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 0.15 |
Financial Position
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | 21.00 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 34.31 |
| Return on Assets (ROA) | 6.25 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 28.64 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Oscar Health, Inc. has paid 38.88M in income taxes, reflecting an effective tax rate of 6.59.
| Income Tax | 38.88M |
| Effective Tax Rate | 6.59 |
Stock Price Statistics
Oscar Health, Inc.'s stock has gained approximately 83.54877% over the past 52 weeks. The 50-day moving average sits at 30.13, while the 200-day moving average is 19.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | 83.54877% |
| 50-Day Moving Average | 30.13 |
| 200-Day Moving Average | 19.93 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Oscar Health, Inc. generated 15.32B in revenue and converted that into 550.74M in net income, yielding earnings per share of 1.83.
| Revenue | 15.32B |
| Gross Profit | N/A |
| Operating Income | N/A |
| Pretax Income | 589.81M |
| Net Income | 550.74M |
| EBITDA | N/A |
| EBIT | N/A |
| Earnings Per Share (EPS) | 1.83 |
Balance Sheet
Oscar Health, Inc. holds 8.56B in cash and equivalents against 431.63M in total debt, resulting in a net debt position of -3.64B.
| Cash & Cash Equivalents | 8.56B |
| Total Debt | 431.63M |
| Net Debt | -3.64B |
| Equity (Book Value) | 2.05B |
| Book Value Per Share | 6.65 |
| Working Capital | N/A |
Cash Flow
Oscar Health, Inc. produced 4.42B in operating cash flow over the past twelve months. After subtracting -38.62M in capital expenditures, free cash flow totaled 4.38B - equivalent to 15.33 per share.
| Operating Cash Flow | 4.42B |
| Capital Expenditures | -38.62M |
| Free Cash Flow | 4.38B |
| FCF Per Share | 15.33 |
Margins
Oscar Health, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics.
| Gross Margin | 100.00 |
| Operating Margin | N/A |
| Pretax Margin | 3.85 |
| Profit Margin | 3.60 |
| EBITDA Margin | N/A |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -4.34 |
| FCF Yield | 51.85 |
Scores
Oscar Health, Inc. posts an Altman Z-Score of 1.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.66 |